sultamicillin and Genital-Diseases--Male

sultamicillin has been researched along with Genital-Diseases--Male* in 2 studies

Other Studies

2 other study(ies) available for sultamicillin and Genital-Diseases--Male

ArticleYear
Comparison of Neisseria gonorrhoeae isolates from the genital tract and pharynx of two gonorrhea patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2001, Volume: 7, Issue:3

    Neisseria gonorrhoeae was isolated simultaneously from urethral and pharyngeal specimens of two gonorrhea patients. The pair of isolates from one of the two patients were identical in auxotype, pulsed-field gel electrophoresis pattern, and antimicrobial susceptibility, which indicated that both sites in that patient were infected with the same strain of N. gonorrhoeae. However, the two isolates from the other patient had different properties, indicating that the two sites in the second patient were infected with different strains. The gonococcal infections in these patients failed to respond to initial treatment with sparfloxacin or sulbactam/ampicillin, because the causative strains of N. gonorrhoeae were resistant to the respective antibiotics. Variable patterns and routes of gonococcal infection have recently been discovered in individual patients, suggesting that specimens for bacterial isolation should be taken not just from one site but from various sites that might be infected. This method may contribute to the successful treatment and epidemiological investigation of gonococcal infections.

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genital Diseases, Male; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngeal Diseases; Pharynx; Spectinomycin; Sulbactam; Urethra

2001
[The use of ampicillin/sulbactam (Unasyn) in treating inflammatory urological diseases].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1991, Volume: 36, Issue:6

    Unasyn is a combination of ampicillin, a bactericidal antibiotic, and sulbactam, an inhibitor of beta-lactamases. It was used in treatment of 36 patients with urogenital infections. The combination was administered intravenously and in the main intramuscularly. The treatment course amounted to 7-10 days. The average daily dose was 6 to 9 g. 22 patients with acute nonocclusive pyelonephritis were treated with the combination and its clinical and bacteriological efficacy was stated in 95 per cent of the cases. An excellent clinical effect of the combination was observed in 6 patients with acute epididymitis. A clinical improvement was also observed in the treatment of the patients with acute prostatitis and chronic renal infections. Unasyn proved to be a highly efficient antibacterial combination with regard to gram-positive flora and colon bacilli as representatives of gram-negative organisms. Satisfactory results were also stated in the treatment of infections caused by Proteus spp. Complete elimination of the pathogen was achieved in 57.7 per cent of the cases. No adverse reactions to Unasyn except pain in the site of the injection were recorded.

    Topics: Adolescent; Adult; Aged; Ampicillin; Bacteria; Child; Drug Evaluation; Drug Therapy, Combination; Genital Diseases, Male; Humans; Inflammation; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Urinary Tract Infections

1991